PsyBio Therapeutics Insider ownership
What is the Insider ownership of PsyBio Therapeutics?
The Insider ownership of PsyBio Therapeutics Corp. is 20.31%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on TSXV compared to PsyBio Therapeutics
What does PsyBio Therapeutics do?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Companies with insider ownership similar to PsyBio Therapeutics
- Kingdee International Software has Insider ownership of 20.29%
- Sino Splendid has Insider ownership of 20.29%
- Nucleus Plc has Insider ownership of 20.29%
- ZW Data Action Technologies Inc has Insider ownership of 20.29%
- Vimy Resources has Insider ownership of 20.30%
- Halo Labs has Insider ownership of 20.31%
- PsyBio Therapeutics has Insider ownership of 20.31%
- Elevate Credit has Insider ownership of 20.32%
- Venus Medtech (Hangzhou) Inc has Insider ownership of 20.33%
- Venus Medtech (Hangzhou) has Insider ownership of 20.33%
- Acasti Pharma has Insider ownership of 20.33%
- MYCELX Technologies has Insider ownership of 20.34%
- engage:BDR has Insider ownership of 20.35%